Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders
Authors
Keywords
-
Journal
PSYCHOLOGICAL MEDICINE
Volume -, Issue -, Pages 1-11
Publisher
Cambridge University Press (CUP)
Online
2021-02-09
DOI
10.1017/s0033291720004778
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
- (2020) Maximilian Huhn et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment
- (2019) Ira D. Glick et al. CNS SPECTRUMS
- Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
- (2019) Antonio Vita et al. Frontiers in Pharmacology
- Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
- (2019) Davide Amato et al. Frontiers in Psychiatry
- Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope?
- (2019) Federico E Turkheimer et al. SCHIZOPHRENIA BULLETIN
- Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review
- (2019) Joanna Moncrieff et al. SCHIZOPHRENIA RESEARCH
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first episode psychosis: a positron emission tomography study.
- (2018) Sameer Jauhar et al. BIOLOGICAL PSYCHIATRY
- Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics
- (2018) Robin M. Murray et al. World Psychiatry
- Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?
- (2018) Martin Harrow et al. World Psychiatry
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
- (2018) JP Kesby et al. Translational Psychiatry
- Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia
- (2018) Kengo Oishi et al. PLoS One
- Early recovery and employment outcome 13 years after first episode psychosis
- (2018) Pontus Strålin et al. PSYCHIATRY RESEARCH
- Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?
- (2017) Ira D. Glick et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice
- (2017) Yusuke Nakata et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
- (2017) A H Ashok et al. MOLECULAR PSYCHIATRY
- A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia
- (2017) Martin Harrow et al. PSYCHIATRY RESEARCH
- Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
- (2017) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
- (2017) Sameer Jauhar et al. JAMA Psychiatry
- Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
- (2016) Robin M. Murray et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
- (2016) John Yin et al. Current Neuropharmacology
- Precision medicine for psychopharmacology: a general introduction
- (2016) Cheolmin Shin et al. Expert Review of Neurotherapeutics
- Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes
- (2016) Luigi F. Agnati et al. REVIEWS IN THE NEUROSCIENCES
- Precision medicine for psychopharmacology: a general introduction
- (2016) Cheolmin Shin et al. Expert Review of Neurotherapeutics
- Antipsychotic medication in schizophrenia: a review
- (2015) John Lally et al. BRITISH MEDICAL BULLETIN
- 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity
- (2015) Alexandra Charron et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
- (2015) Yasunori Oda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
- (2015) Masayuki Takase et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
- (2015) Tomotaka Suzuki et al. PSYCHIATRY RESEARCH
- Multiplexing signals in reinforcement learning with internal models and dopamine
- (2014) Hiroyuki Nakahara CURRENT OPINION IN NEUROBIOLOGY
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
- (2014) C. Morgan et al. PSYCHOLOGICAL MEDICINE
- Longitudinal Study of Remission Among Older Adults with Schizophrenia Spectrum Disorder
- (2013) Carl I. Cohen et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach
- (2013) Leslie Citrome CNS DRUGS
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
- (2013) M. Harrow et al. SCHIZOPHRENIA BULLETIN
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Long-Term Follow-Up of the TIPS Early Detection in Psychosis Study: Effects on 10-Year Outcome
- (2012) Wenche ten Velden Hegelstad et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study
- (2012) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression
- (2011) Joseph F Goldberg et al. BIPOLAR DISORDERS
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- Dopamine neurons code subjective sensory experience and uncertainty of perceptual decisions
- (2011) V. de Lafuente et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
- (2010) Paul Fallon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Hospital use of antipsychotic drugs: polytherapy
- (2007) Franca Centorrino et al. COMPREHENSIVE PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started